IRIS - Res&Arch Institutional Research Information System - Research & Archive

IRACI, NUNZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.342
EU - Europa 1.733
AS - Asia 1.542
SA - Sud America 290
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 5.938
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.295
SG - Singapore 559
UA - Ucraina 359
IE - Irlanda 291
VN - Vietnam 290
BR - Brasile 257
CN - Cina 242
HK - Hong Kong 236
SE - Svezia 235
IT - Italia 209
RU - Federazione Russa 190
GB - Regno Unito 114
DE - Germania 106
FI - Finlandia 93
KR - Corea 66
TR - Turchia 51
BE - Belgio 35
AR - Argentina 20
CA - Canada 19
FR - Francia 19
IN - India 18
MX - Messico 17
AT - Austria 15
PL - Polonia 15
BD - Bangladesh 12
CH - Svizzera 11
NL - Olanda 11
ES - Italia 9
JP - Giappone 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
ID - Indonesia 8
IQ - Iraq 7
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
RO - Romania 5
CI - Costa d'Avorio 4
EU - Europa 4
MA - Marocco 4
PK - Pakistan 4
PY - Paraguay 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
JO - Giordania 3
NP - Nepal 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EG - Egitto 2
GD - Grenada 2
IR - Iran 2
JM - Giamaica 2
PA - Panama 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BH - Bahrain 1
BZ - Belize 1
CL - Cile 1
CM - Camerun 1
CO - Colombia 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LT - Lituania 1
ML - Mali 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.938
Salva come PNG Salva come JPEG
Città #
Singapore 371
Chandler 349
Dublin 289
Hong Kong 230
Dong Ket 211
Jacksonville 190
San Mateo 180
Ashburn 119
Perugia 103
Boardman 98
Santa Clara 88
Medford 77
Princeton 76
Seoul 66
Andover 65
Fremont 64
Beijing 63
Moscow 59
Wilmington 54
Dearborn 52
The Dalles 50
Ann Arbor 48
Izmir 40
Altamura 35
São Paulo 35
Brussels 34
Ho Chi Minh City 30
Lawrence 30
Piscataway 29
Los Angeles 28
Norwalk 23
Saint Petersburg 23
West Jordan 20
New York 18
Hanoi 16
Des Moines 15
Munich 14
Warsaw 14
Hefei 13
San Giustino 13
Helsinki 12
Brooklyn 11
Dallas 10
Redmond 10
Atlanta 9
Falls Church 9
Houston 9
Nanjing 9
Tokyo 9
Brasília 8
Stockholm 8
Auburn Hills 7
Chicago 7
Manchester 7
Montreal 7
Philadelphia 7
Shanghai 7
Simi Valley 7
Belo Horizonte 6
Chennai 6
Denver 6
Johannesburg 6
Phoenix 6
Poplar 6
Recife 6
Redwood City 6
Rome 6
San Diego 6
San Francisco 6
Toronto 6
Zhengzhou 6
Ankara 5
Charlotte 5
Columbus 5
Den Haag 5
Guangzhou 5
Jinan 5
Lappeenranta 5
London 5
San Paolo di Civitate 5
Spoleto 5
Teresina 5
Turku 5
Vienna 5
Woodbridge 5
Abidjan 4
Asunción 4
Biên Hòa 4
Boston 4
Buenos Aires 4
Mcallen 4
Ribeirão Preto 4
Salvador 4
Amman 3
Amsterdam 3
Birmingham 3
Buffalo 3
Chengdu 3
Goiânia 3
Hangzhou 3
Totale 3.686
Salva come PNG Salva come JPEG
Nome #
1,3-DIIDRO-BENZIMIDAZOLONI ANALOGHI: PROGETTAZIONE, SINTESI E SAR DI NUOVI INIBITORI NON-NUCLEOSIDICI DELL’RT 301
1,3-Diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 295
beta-CYCLODEXTRIN HINDERS PLGA PLASTICIZATION DURING MICROPARTICLE MANUFACTURING 167
Prion protein ligands as therapeutic agents for neurodegenerative disorders 133
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 113
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 109
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 108
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 102
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 98
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 98
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 98
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 96
Binding Mode Prediction of Strand Transfer HIV-1 Integrase Inhibitors Using Tn5 Transposase as a Plausible Surrogate Model for HIV-1 Integrase 95
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 92
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 91
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model. 91
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 90
Design and synthesis of NR2B Subtype-Selective Antagonist 89
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 89
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 88
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non–Nucleoside reverse Transcriptase Inhibitors 86
Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors. 86
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 86
Nuovi antagonisti non-competitivi del recettore NMDA/NR2B:design and sintesi 85
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 85
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 85
Diselenides and benzisoselenazolones as antiproliferative agents and glutathione-S-transferase inhibitors 84
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 83
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 83
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 82
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 81
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 80
DECODING THE FUNCTION OF THE N-TERMINAL TAIL OF THE CELLULAR PRION PROTEIN TO INSPIRE NOVEL THERAPEUTIC AVENUES FOR NEURODEGENERATIVE DISEASES 80
Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with beta-cyclodextrin. 77
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 73
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 73
Exploration of the binding mode of HIV-1 integrase strand transfer inhibitors through different computational approaches. 72
Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 72
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 69
Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell’ HIV-1 Mediante Tecniche di Virtual screening. 69
Sviluppo di modello farmacoforico predittivo per gli NR2B antagonisti del recettore NMDA 68
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 68
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 68
Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors. ChemMedChem 67
Nuovo modello farmacoforico per inibitori dell’Integrasi dell’HIV-1: ottimizzazione della potenza di composti a struttura 1H-benzilindolica 65
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors. 65
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series. 65
Nuovi chemotipi di inibitori dell'HCV NS5B polimerasi 64
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 62
HIV-1-IN Strand-Transfer Inhibitors: phenyl ring exploration and synthesis of 1H-benzylindole derivative through fluorine substitutions 61
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 61
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 61
New chemotypes to fight HCV infection: discovery of selective inhibitors of HCV replication with pyrazolobenzothiazine scaffold 60
Tn5 Transposase as a useful platform to simulate HIV-1 Integrase inhibitor binding mode 60
Structure-Based Discovery of Pyrazolobenzothiazine Derivatives As Inhibitors of Hepatitis C Virus Replication 60
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 59
Rational design, synthesis and SAR of 1,3-dihydro- benzimidazolone analogues as new anti-HIV agents 59
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-Dioxide: A Promising New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors 59
Studi Computazionali per l’Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell’HIV- 57
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors. 56
INTEGRASE STRAND TRANSFER INHIBITORS (INSTIs): SYNTHESIS AND ANTIVIRAL EFFETCS OF CHLORO-FLUORO SUBSTITUTIONS 55
Pharmacological agents targeting the cellular prion protein 55
Docking studies on a new HIV integrase–Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 55
Targeting the HIV Tat-mediated transcriptional machinery: P-TEFb complex inhibitors 54
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 53
Pharmacophore Modeling, Docking Experiments And Discovery Of New HIV-1 NNRTIs. 51
TARGETING CDKs TO INHIBIT THE HIV-1 TAT-MEDIATED TRANSCRIPTION 51
The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors 51
NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors 51
Progettazione, sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 50
Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. 50
NCp7: Targeting a multitask protein for next-generation anti-HIV drug development part 2. Noncovalent inhibitors and nucleic acid binders 50
From Small to Powerful: The Fragments Universe and its "Chem-Appeal" 48
Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. 47
Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. 46
Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents. 43
L-arginine improves solubility and anti sars-cov-2 mpro activity of rutin but not the antiviral activity in cells 34
Totale 6.123
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021540 0 0 0 0 0 77 59 5 94 26 56 223
2021/2022708 16 135 12 37 47 7 5 231 27 15 88 88
2022/2023989 82 141 15 91 82 109 0 56 356 2 33 22
2023/2024481 36 62 23 11 5 8 73 35 63 29 68 68
2024/2025984 2 104 27 107 99 12 76 25 197 98 159 78
2025/20261.128 160 177 106 303 228 154 0 0 0 0 0 0
Totale 6.123